SANTEN PHARMACEUTICAL CO earnings per share and revenue

4536/N earnings per share for the last quarter are 3.19 MXN whereas the estimation was 2.97 MXN which accounts for 7.37% surprise. Company revenue for the same period amounts to 9.82 B MXN despite the estimated figure of 10.23 B MXN. Estimated earnings per share for the next quarter are 3.20 MXN, and revenue is expected to reach 9.71 B MXN. Also watch annual changes over time to get a bigger picture of 4536/N earnings per share and revenue dynamics.